UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

The EPMA journal, 2010-09, Vol.1 (3), p.397-412

Janavičius, Ramūnas

2010

Volltextzugriff (PDF)

Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and Latvia

Gastroenterology research and practice, 2015-01, Vol.2015, p.204089-10

2015

Volltextzugriff (PDF)

Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer

PLoS genetics, 2016-08, Vol.12 (8), p.e1006248-e1006248

2016

Volltextzugriff (PDF)

Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania

Cancer genetics, 2014-05, Vol.207 (5), p.195-205

2014

Volltextzugriff (PDF)

Overlapping Phenotype of Cardiomyopathy in a Patient with Double Mutation: A Case Report

Cardiogenetics, 2021-03, Vol.11 (1), p.31-38

2021

Volltextzugriff (PDF)

Genetic counselling legislation and practice in cancer in EU Member States

European journal of public health, 2024-08, Vol.34 (4), p.666-675

2024

Volltextzugriff (PDF)

Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania

Breast cancer research and treatment, 2009-09, Vol.117 (2), p.467-469

2009

Volltextzugriff (PDF)

Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation

European journal of medical genetics, 2013-03, Vol.56 (3), p.125-130

2013

Volltextzugriff (PDF)

A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies

Journal of clinical medicine, 2023-08, Vol.12 (17), p.5502

2023

Volltextzugriff (PDF)

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Genetics in medicine, 2021-09, Vol.23 (9), p.1726-1737

2021

Volltextzugriff (PDF)

Multiple endocrine neoplasia type 1: a case report and review of the literature

Central European journal of medicine, 2014-06, Vol.9 (3), p.424-430

2014

Volltextzugriff (PDF)

Extremely low risk of pheochromocytomas in complete VHL gene deletion cases

Human mutation, 2009-09, Vol.30 (9), p.1365-1366

2009

Volltextzugriff (PDF)

BRCA1 testing in Lithuania

Hereditary cancer in clinical practice, 2012-01, Vol.10 (Suppl 4), p.A9-A9

Janavicius, Ramunas

2012

Volltextzugriff (PDF)

Apparently “BRCA‐Related” Breast and Ovarian Cancer Patient With Germline TP53 Mutation

The breast journal, 2011-07, Vol.17 (4), p.409-415

2011

Volltextzugriff (PDF)

Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers

Hereditary cancer in clinical practice, 2012-01, Vol.10 (1), p.1-1, Article 1

2012

Volltextzugriff (PDF)

Abstract LB-044: Germline mutations in patients with hereditary breast and ovarian cancer establish ERCC2 as a cancer susceptibility gene

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.LB-044-LB-044

2015

Volltextzugriff (PDF)

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Nature genetics, 2020-06, Vol.52 (6), p.572-581

2020

Volltextzugriff (PDF)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1529-1541

2022

Volltextzugriff (PDF)

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Human mutation, 2018-05, Vol.39 (5), p.593-620

2018

Volltextzugriff (PDF)

A Novel Mutation of IMSH2/I Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies

Journal of clinical medicine, 2023-08, Vol.12 (17)

2023

Volltextzugriff (PDF)

The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study

European journal of obstetrics & gynecology and reproductive biology, 2020-04, Vol.247, p.26-31

2020

Volltextzugriff (PDF)

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2240-2250

2017

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Nature communications, 2019-04, Vol.10 (1), p.1741-18, Article 1741

2019

Volltextzugriff (PDF)

Microsatellite Instability Detection by High-Resolution Melting Analysis

Clinical chemistry (Baltimore, Md.), 2010-11, Vol.56 (11), p.1750-1757

2010

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(65)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and Latvia

Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer

Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania

Overlapping Phenotype of Cardiomyopathy in a Patient with Double Mutation: A Case Report

Genetic counselling legislation and practice in cancer in EU Member States

Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania

Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation

A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Multiple endocrine neoplasia type 1: a case report and review of the literature

Extremely low risk of pheochromocytomas in complete VHL gene deletion cases

BRCA1 testing in Lithuania

Apparently “BRCA‐Related” Breast and Ovarian Cancer Patient With Germline TP53 Mutation

Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers

Abstract LB-044: Germline mutations in patients with hereditary breast and ovarian cancer establish ERCC2 as a cancer susceptibility gene

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

A Novel Mutation of IMSH2/I Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies

The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Microsatellite Instability Detection by High-Resolution Melting Analysis

Suchergebnisse filtern